valopicitabine

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis C

Phase 1

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

CompletedNCT00120835

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2004-07-31Updated: 2010-06-10

Phase 2

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

CompletedNCT00118768

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2005-08-31Target: 175Updated: 2009-03-02

Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy

CompletedNCT00120861

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2005-01-31Updated: 2010-06-10